Neptune UK Mid Cap Fund C Acc GBP
|Devro PLC||9.76 %|
|NCC Group PLC||8.98 %|
|Spirent Communications PLC||7.87 %|
|De La Rue PLC||7.49 %|
|Consort Medical PLC||5.21 %|
|Essentra PLC||4.63 %|
|Chemring Group PLC||4.54 %|
|ITE Group PLC||4.48 %|
|PayPoint PLC||4.43 %|
|Equiniti Group PLC||4.36 %|
|United Kingdom||99.15 %|
|Consumer Defensive||13.12 %|
|Consumer Cyclical||12.42 %|
|Communication Services||11.36 %|
Mark joined Neptune in February 2008 as a Senior Analyst and has since become a Fund Manager and Head of UK Equities. Mark graduated from Oxford University in Classics in 2002. He then went on to qualify as a solicitor at Allen & Overy, in the Private Equity group. Mark undertakes global research on the healthcare sector.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.